Skip to main navigation Skip to search Skip to main content

Efficacy, patterns of relapse and safety of adjuvant treatment with intraperitoneal (i.p.) yttrium-90-labeled HMFG1 monoclonal antibody (R1549) in epithelial ovarian cancer (EOC)

  • LFAG Massuger
  • , A. Lopes
  • , AA Epenetos
  • , M.V. Seiden
  • , BB Benigno
  • , JT Soper
  • , J. Markowska
  • , R Vyzula
  • , RHM Verheijen
  • , T Jobling

Research output: Contribution to conferenceAbstractOther research output

Original languageEnglish
Publication statusPublished - 2004
EventIGCS - Edinburgh, Ireland
Duration: 3 Oct 20048 Oct 2016

Conference

ConferenceIGCS
Country/TerritoryIreland
CityEdinburgh
Period3/10/048/10/16

Cite this